Rob Barto Selected Research

Bile Acids and Salts (Bile Acids)

1/2023

Newborn screening for Cerebrotendinous Xanthomatosis: A retrospective biomarker study using both flow-injection and UPLC-MS/MS analysis in 20,000 newborns.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rob Barto Research Topics

Disease

2	Type 2 Diabetes Mellitus (MODY) 03/2011 - 07/2007
1	Cerebrotendinous Xanthomatosis 01/2023
1	Diabetes Complications 03/2011
1	Diabetic Angiopathies (Diabetic Angiopathy) 04/2008
1	Atherosclerosis 01/2005
1	Renal Insufficiency (Renal Failure) 03/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2004
1	Inflammation (Inflammations) 03/2004

Drug/Important Bio-Agent (IBA)

3	Advanced Glycation End ProductsIBA 04/2008 - 03/2004
1	Bile Acids and Salts (Bile Acids)IBA 01/2023
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 03/2011
1	3-deoxyglucosoneIBA 03/2011
1	repaglinide (Prandin)FDA Link 03/2011
1	Pyruvaldehyde (Methylglyoxal)IBA 04/2008
1	oxidized low density lipoproteinIBA 07/2007
1	LDL CholesterolIBA 07/2007
1	Glucose (Dextrose)FDA LinkGeneric 07/2007
1	CarbohydratesIBA 07/2007
1	Peptides (Polypeptides)IBA 01/2005
1	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 03/2004
1	N(6)-(1-carboxyethyl)lysineIBA 03/2004
1	C-Reactive ProteinIBA 03/2004
1	EnzymesIBA 03/2004
1	ImmunosorbentsIBA 03/2004
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2004
1	von Willebrand FactorIBA 03/2004
1	ThrombomodulinIBA 03/2004
1	E-SelectinIBA 03/2004
1	SelectinsIBA 03/2004

Therapy/Procedure

1	Glycemic Control 03/2011